Positively Aware Baraclude HBV

Baraclude

entecavir (ETV)

 
Nucleoside "Nuke"

Standard Dose

For adults (age 16 years and older) who are treatment-naïve (no previous hepatitis B therapy) with no drug resistance, take one 0.5 mg tablet once daily. If there is drug resistance to lamivudine (Epivir) or telbivudine (Tyzeka, discontinued since December 2016), take one 1 mg tablet once daily. Adults with decompensated liver disease (Child-Pugh B or C): one 1 mg tablet once daily. Baraclude should always be taken on an empty stomach (no food 2 hours before, or 2 hours after, taking Baraclude).

Dose adjustments needed for individuals with kidney disease (see chart below). Baraclude is safe to use in children ages 2 years and older, weighing at least 22 pounds (10 kg) or more. Dosing for children is based on weight and should be done in consultation with an experienced medical provider. An oral solution (0.05 mg/mL) is also available for children or as reduced doses in people with kidney disease.

Manufacturer

Bristol-Myers Squibb

AWP

Baraclude
0.5 mg and 1 mg tablets: $1,647 / month
0.05 mg/mL solution (equivalent of 0.5–1 mg daily): $1,647–$3,294 / month
Generic
0.5 mg and 1 mg tablets: $1,332–1,800 / month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information